Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States.
Undervalued with solid track record.
Share Price & News
How has Anthem's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ANTM has not had significant price volatility in the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: ANTM underperformed the US Healthcare industry which returned 14.2% over the past year.
Return vs Market: ANTM underperformed the US Market which returned 4.8% over the past year.
Price Volatility Vs. Market
How volatile is Anthem's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StAnthem (NYSE:ANTM) Is Growing Earnings But Are They A Good Guide?
3 weeks ago | Simply Wall StIf You Like EPS Growth Then Check Out Anthem (NYSE:ANTM) Before It's Too Late
1 month ago | Simply Wall StIs Anthem, Inc.'s(NYSE:ANTM) Recent Stock Performance Tethered To Its Strong Fundamentals?
Is Anthem undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: ANTM ($267) is trading below our estimate of fair value ($832.72)
Significantly Below Fair Value: ANTM is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: ANTM is good value based on its PE Ratio (14.2x) compared to the Healthcare industry average (24x).
PE vs Market: ANTM is good value based on its PE Ratio (14.2x) compared to the US market (16.5x).
Price to Earnings Growth Ratio
PEG Ratio: ANTM is poor value based on its PEG Ratio (1.3x)
Price to Book Ratio
PB vs Industry: ANTM is good value based on its PB Ratio (2.1x) compared to the US Healthcare industry average (2.7x).
How is Anthem forecast to perform in the next 1 to 3 years based on estimates from 15 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ANTM's forecast earnings growth (11.2% per year) is above the savings rate (2.2%).
Earnings vs Market: ANTM's earnings (11.2% per year) are forecast to grow slower than the US market (22.8% per year).
High Growth Earnings: ANTM's earnings are forecast to grow, but not significantly.
Revenue vs Market: ANTM's revenue (7.2% per year) is forecast to grow slower than the US market (9.3% per year).
High Growth Revenue: ANTM's revenue (7.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ANTM's Return on Equity is forecast to be low in 3 years time (16.4%).
How has Anthem performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ANTM has high quality earnings.
Growing Profit Margin: ANTM's current net profit margins (4.4%) are higher than last year (4.2%).
Past Earnings Growth Analysis
Earnings Trend: ANTM's earnings have grown by 14.4% per year over the past 5 years.
Accelerating Growth: ANTM's earnings growth over the past year (19.8%) exceeds its 5-year average (14.4% per year).
Earnings vs Industry: ANTM earnings growth over the past year (19.8%) exceeded the Healthcare industry 10.1%.
Return on Equity
High ROE: ANTM's Return on Equity (15.1%) is considered low.
How is Anthem's financial position?
Financial Position Analysis
Short Term Liabilities: ANTM's short term assets ($41.3B) exceed its short term liabilities ($27.0B).
Long Term Liabilities: ANTM's short term assets ($41.3B) exceed its long term liabilities ($23.7B).
Debt to Equity History and Analysis
Debt Level: ANTM's debt to equity ratio (69.8%) is considered high.
Reducing Debt: ANTM's debt to equity ratio has reduced from 73.5% to 69.8% over the past 5 years.
Debt Coverage: ANTM's debt is well covered by operating cash flow (31.4%).
Interest Coverage: ANTM's interest payments on its debt are well covered by EBIT (9.2x coverage).
What is Anthem current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: ANTM's dividend (1.42%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.67%).
High Dividend: ANTM's dividend (1.42%) is low compared to the top 25% of dividend payers in the US market (4.51%).
Stability and Growth of Payments
Stable Dividend: Whilst dividend payments have been stable, ANTM has been paying a dividend for less than 10 years.
Growing Dividend: ANTM's dividend payments have increased, but the company has only paid a dividend for 9 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (17.8%), ANTM's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: ANTM's dividends in 3 years are forecast to be thoroughly covered by earnings (13.6% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Gail Boudreaux (59yo)
Ms. Gail Koziara Boudreaux has been President, Chief Executive Officer and Director of Anthem, Inc. since November 11, 2017. Prior to joining the Company, she served as Chief Executive Officer of GKB Globa ...
CEO Compensation Analysis
Compensation vs Market: Gail's total compensation ($USD15.47M) is above average for companies of similar size in the US market ($USD11.50M).
Compensation vs Earnings: Gail's compensation has been consistent with company performance over the past year.
|Executive VP & CFO||4.08yrs||US$5.11m||0.017% $11.2m|
|Executive VP and Chief Administration Officer||7.5yrs||US$5.25m||0.017% $11.2m|
|Executive VP and President of Commercial & Specialty Business Division||6.08yrs||US$5.08m||0.016% $10.4m|
|Executive VP & President of Government Business Division||2.08yrs||US$7.92m||0.00037% $249.1k|
|SVP, Treasurer & Chief Investment Officer||2.25yrs||no data||no data|
|Senior VP||4.58yrs||no data||0.0015% $989.5k|
|Senior VP & Chief Information Officer||6.17yrs||no data||no data|
|Vice President||2.5yrs||no data||no data|
|Executive VP & General Counsel||6.08yrs||US$3.98m||0.0082% $5.5m|
Experienced Management: ANTM's management team is considered experienced (4.3 years average tenure).
|Independent Director||15.67yrs||US$376.38k||0.0025% $1.7m|
|Independent Chairman of the Board||2.17yrs||US$564.40k||no data|
|Independent Director||15.67yrs||US$371.38k||no data|
|Independent Director||7yrs||US$343.61k||no data|
|Independent Director||6.17yrs||US$330.84k||no data|
|Independent Director||9yrs||US$344.52k||0.0020% $1.4m|
|Member of Advisory Board||6.92yrs||no data||no data|
|Member of Advisory Board||6.92yrs||no data||no data|
|Chairman of Advisory Board & National Optometric Director||6.92yrs||no data||no data|
Experienced Board: ANTM's board of directors are considered experienced (6.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ANTM insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Anthem, Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Anthem, Inc.
- Ticker: ANTM
- Exchange: NYSE
- Founded: 1944
- Industry: Managed Health Care
- Sector: Healthcare
- Market Cap: US$67.315b
- Shares outstanding: 252.12m
- Website: https://www.antheminc.com
Number of Employees
- Anthem, Inc.
- 220 Virginia Avenue
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ANTM||NYSE (New York Stock Exchange)||Yes||Common Stock||US||USD||Oct 2001|
|A58||DB (Deutsche Boerse AG)||Yes||Common Stock||DE||EUR||Oct 2001|
|ANTM *||BMV (Bolsa Mexicana de Valores)||Yes||Common Stock||MX||MXN||Oct 2001|
|0HG8||LSE (London Stock Exchange)||Yes||Common Stock||GB||USD||Oct 2001|
|A58||ETLX (Eurotlx)||Yes||Common Stock||IT||EUR||Oct 2001|
|ANTM||WBAG (Wiener Boerse AG)||Yes||Common Stock||AT||EUR||Oct 2001|
|A1NT34||BOVESPA (Bolsa de Valores de Sao Paulo)||BDR EACH 5 REPR 1 SHS UNSPON||BR||BRL||Jan 2020|
Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2019, it served 41 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/07/02 23:51|
|End of Day Share Price||2020/07/02 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.